Access to Pancreatic Cancer Treatments: Pancreatic Cancer Canada CEO Michelle Capobianco Speaks to Newstalk 1010 Michelle Capobianco, Chief Executive Officer of Pancreatic Cancer Canada, speaks with John Moore of Newstalk 1010 about the bureaucracy that prevents new...
OUR IMPACT: 2019 OUR IMPACT: 2019 A Year In Review 2019 was a year of growth, inspiration and tenacity. We set out to make significant research and awareness investments, grow our support programs, and further our partnerships to deliver services and...
Promising Treatment for Deadly Cancer Blocked by Canadian Regulators See original press release on Newswire TORONTO, Aug. 19, 2020 /CNW Telbec/ – While innovations in health care are spurring extraordinary advances in the treatment of malignant tumours,...
Community fundraiser adapts amidst global pandemic Dedicated. Resilient. Compassionate. These are just a few words that describe Pam Kosolofski, a steadfast champion of progress for pancreatic cancer patients – even amidst a global pandemic. Each spring, Pam organizes...
Pancreatic Cancer Care in the Age of Physical Distancing The advent of physical distancing measures has led to many questions from our pancreatic cancer community – from whether you can still get a second opinion to whether patients should continue with their...
PCC Funded COMPASS Trial Leads to the Discovery of Five New Subtypes of Pancreatic Cancer We are excited to share the recent success of the COMPASS trial, a research study funded in part by Pancreatic Cancer Canada, that has announced the discovery of five distinct...
Recent Comments